Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 4 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Nanjing Nutrabuilding Bio-Tech Co. Ltd. currently has 7 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 7 distinct examiners, which indicates that no single examiner is handling multiple cases for the company at this time. This distribution suggests a diverse range of inquiries within the portfolio's current prosecution cycle.
The portfolio's workload is further distributed across 4 distinct art units. This variety highlights that the company's Biotechnology & Pharmaceuticals interests are being reviewed by several different specialized groups within the patent office. The busiest examiner, RAO, SAVITHA M, is responsible for 1 pending office action. Because this busiest examiner's pending count is 1 while the total count of 7 distinct examiners is the same as the total action count, the workload is perfectly distributed across the identified individuals.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §103 only | 2 (29%) |
| Double-patenting + other | 1 (14%) |
| Multi-statute (no §101) | 3 (43%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAO, SAVITHA M | 1 | 60.7% | +30.2% |
| KWON, JOHN SEUNGJAI | 1 | 45.7% | +19.3% |
| SEAMAN, D MARGARET M | 1 | 76.5% | +8.0% |
| KIM, SEONG JONG | 1 | 25.0% | +0.0% |
| SHI, GENBIN | 1 | — | — |
| HEASLEY, MEGHAN CHRISTINE | 1 | 75.2% | +34.0% |
| ISMAIL, REHANA | 1 | 75.8% | +34.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18422930 | L-ERGOTHIONEINE AND USES THEREOF | KIM, SEONG JONG | 22d |
| 17975028 | USE OF DIHYDROBERBERINE OR ITS DERIVATIVES FOR ANTI-AGING | ISMAIL, REHANA | 33d |
| 18392229 | USE OF L-ERGOTHIONEINE FOR ALLEVIATING AND PREVENTING AGE-RELATED VISUAL DEGENERATION | SHI, GENBIN | 34d |
| 18785602 | Compositions and Methods for Preventing or Improving Premature Skin Aging | KWON, JOHN SEUNGJAI | — |
| 18626324 | Method and Composition for Mimicking Caloric Restriction by Administration of Ergothioneine | SEAMAN, D MARGARET M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17975028 | USE OF DIHYDROBERBERINE OR ITS DERIVATIVES FOR ANTI-AGING | ISMAIL, REHANA | 33d |
| 18895434 | COMPOSITIONS AND METHODS FOR PROMOTING GLYCOGEN SYNTHASE ACTIVITY AND AUGMENTING GLYCOGEN STORAGE CAPABILITY | RAO, SAVITHA M | — |
| 18785602 | Compositions and Methods for Preventing or Improving Premature Skin Aging | KWON, JOHN SEUNGJAI | — |
| 18517037 | BETA-HYDROXYBUTYRATE WITH PURE BIOBASED CARBON CONTENT AND METHODS FOR PRODUCING THE SAME | HEASLEY, MEGHAN CHRISTINE | — |
| Art Unit | Apps |
|---|---|
| 1625 | 2 |
| 1621 | 1 |
| 1628 | 1 |
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18895434 | COMPOSITIONS AND METHODS FOR PROMOTING GLYCOGEN SYNTHASE ACTIVITY AND AUGMENTING GLYCOGEN STORAGE CAPABILITY | RAO, SAVITHA M | — | §102§103DP | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18785602 | Compositions and Methods for Preventing or Improving Premature Skin Aging | KWON, JOHN SEUNGJAI | — | §102§103§112 | Non-Final OA | — | Pending | Jul 26, 2024 |
| 18626324 | Method and Composition for Mimicking Caloric Restriction by Administration of Ergothioneine | SEAMAN, D MARGARET M | 1625 | §101§102§112DP | Non-Final OA | — | Pending | Apr 04, 2024 |
| 18422930 | L-ERGOTHIONEINE AND USES THEREOF | KIM, SEONG JONG | 1621 | §103 | Final Rejection | 22d | Pending | Jan 25, 2024 |
| 18392229 | USE OF L-ERGOTHIONEINE FOR ALLEVIATING AND PREVENTING AGE-RELATED VISUAL DEGENERATION | SHI, GENBIN | 1628 | §102§103§112 | Final Rejection | 34d | Pending | Dec 21, 2023 |
| 18517037 | BETA-HYDROXYBUTYRATE WITH PURE BIOBASED CARBON CONTENT AND METHODS FOR PRODUCING THE SAME | HEASLEY, MEGHAN CHRISTINE | 1626 | §103 | Final Rejection | — | Pending | Nov 22, 2023 |
| 17975028 | USE OF DIHYDROBERBERINE OR ITS DERIVATIVES FOR ANTI-AGING | ISMAIL, REHANA | 1625 | §102§103 | Non-Final OA | 33d | Pending | Oct 27, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial